Clinical Care and Early Detection
Since January 2020, we have diagnosed more than 300 breast and cervical cancers at ICI plus an additional 1800 pathology diagnosis done through ICI with collaborating counties.
ICI prioritizes patient-centered care across the continuum of the patient's journey from advocacy, prevention, screening, early detection, optimal diagnostics-optimal treatments using standardized protocols, palliative & survivorship care, research, and hospice care.
Electronic Medical Record (EMR) and Point of Care (POC)
All our clinical sites are connected to Electronic Medical Records and Essential Clinical Data Management through Open MRS that is modified by ICI’s team of software engineers and the data department. Additionally, ICI utilizes the POC-point of care-Screening for electronic data collection.
ICI has Partnerships with both local and international organizations for a robust M and E framework. We also have an Integrated approach to Community cancer screening, awareness, advocacy, and support the establishment of Facility-based routine screening centers. We also provide mentorship support for these centers within the NCD framework.
Access to Drugs
We promote access programs to drugs e.g. Herceptin, Rituximab, Adcetris, Xeloda making it affordable to many through partnerships with Pharma and county Ministries of Health. We also support Peer-to-peer oncology consultants exchange programs in SSA.
ICI is a partner with the First Ladies Association initiative called EMPOWER project. This is a First-ladies’-led initiative to increase access to screening and early detection services in all counties in Kenya. We also have the Blueprint for Success Meru and Makueni counties in partnership with AMREF, KEHPCA, KEMRI, Elewa Foundation, NCI-Kenya, and the county governments' Ministries of Health.
We provide diagnostic support to counties in partnership with 15 counties in Kenya in a hub-and-spoke model. ICI does all the pathology reviews (we have a full histopathology lab at ICI) for all the counties involved for up to 12 months. The Ventana platform supported by Pharma at ICI is used for IHC.
We have initiated Telemedicine and Telepathology development support. We have also established virtual multidisciplinary tumor boards twice weekly and hosting more than 30 centers across SSA for over a year now.
Besides the Peer-to-peer oncology consultants exchange programs in SSA we support, we also assist in the creation of patient IEC material on common malignancies in Africa.
|Monday – Friday||8.00 – 17.00|
- Address P.O. Box 8088-30100, Nandi Rd., Eldoret
- Email email@example.com
- Phone +254 719 473 446